贤丰控股(002141) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was CNY 312,798,252.98, representing a 96.81% increase compared to CNY 158,936,440.83 in the same period last year[8] - The net profit attributable to shareholders for Q1 2021 was CNY 4,693,041.82, a significant increase of 623.85% from CNY 648,343.31 in the previous year[8] - The net cash flow from operating activities reached CNY 15,954,968.13, marking a 276.59% improvement from a negative cash flow of CNY 9,035,076.61 in the same period last year[8] - Basic earnings per share for Q1 2021 were CNY 0.0041, up 583.33% from CNY 0.0006 in the previous year[8] - The company reported a net loss of ¥442,789,335.17 as of March 31, 2021, slightly improved from a loss of ¥447,404,127.94 at the end of 2020[33] - The total operating revenue for the first quarter of 2021 was CNY 312,798,252.98, an increase of 96.5% compared to CNY 158,936,440.83 in the same period last year[38] - The total operating costs amounted to CNY 315,614,191.38, up 71.4% from CNY 184,162,667.90 year-on-year[39] - The net profit for the first quarter was CNY 1,752,108.95, compared to a net loss of CNY 939,025.89 in the previous year[40] - The company reported a total comprehensive income of CNY 3,776,925.75, compared to a loss of CNY 1,063,193.51 in the previous year[40] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,480,632,200.59, reflecting a 26.85% increase from CNY 1,167,240,757.94 at the end of the previous year[8] - The total assets increased to CNY 1,596,225,517.88, up from CNY 1,262,028,385.96 year-on-year, reflecting a growth of 26.5%[36] - The total liabilities of the company as of March 31, 2021, were ¥631,220,477.09, up from ¥418,612,402.20 at the end of 2020, indicating an increase of about 50.7%[32] - The total liabilities rose to CNY 586,252,991.24, compared to CNY 249,755,661.94 in the previous year, marking an increase of 134.7%[36] - The company's inventory rose to ¥186,543,573.79 from ¥132,252,604.59, marking an increase of approximately 41%[30] Cash Flow - Cash and cash equivalents increased by 333.48% to ¥159,953,811.57 due to the consolidation of Chengdu Tianbang Biological Products Co., Ltd. and Nanjing Shiji Biotechnology Co., Ltd.[16] - Cash flow from operating activities increased by 103.69% to ¥341,530,892.02, attributed to higher sales in the enameled wire business[17] - The cash flow from operating activities generated a net inflow of ¥15,993,341.53, compared to a net outflow of ¥9,035,076.61 in the previous year[46] - The financing activities resulted in a net cash inflow of ¥95,869,066.04, compared to a net outflow of ¥4,214,535.46 in the previous year[47] Government Subsidies - The company received government subsidies amounting to CNY 5,663,656.07 during the reporting period[9] - The company received government subsidies amounting to ¥5,663,656.07, a 63.32% increase compared to the previous year[17] Shareholder Information - The total number of shareholders at the end of the reporting period was 45,763[12] - The net assets attributable to shareholders increased to CNY 787,744,998.41, a slight rise of 0.85% from CNY 781,105,388.84 at the end of the last year[8] Strategic Outlook - The company plans to continue expanding its market presence through strategic acquisitions and investments in new technologies[19] - The company has not disclosed any key performance indicators in the available documents[58][59] - Future outlook and performance guidance are not detailed in the available reports[58][59] Operational Integrity - The company has no overdue or unrecovered amounts related to entrusted financial management, indicating a stable financial management strategy[25] - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period, ensuring financial integrity[26] - The company has not reported any significant contracts or major operational changes during the reporting period, suggesting stability in operations[27] - The company has not conducted any research, communication, or interview activities during the reporting period, indicating a focus on internal operations[27]